Search research articles
Contact Us
Filters
Showing results (91-100 of 394) with videos related to
Page
of 40
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 14, 2023
First Do No Harm? Modeling Risks and Benefits of Challenge Trials for Hepatitis C Vaccine Development
Alyssa Bilinski, Rachel Slimovitch, Andrew Mendlowitz, et al.
Canadian Liver Journal
|
August 22, 2022
Cost-effectiveness of obeticholic acid for the treatment of non-alcoholic steatohepatitis: An early economic evaluation
Chanh-Phong Tran, John J Kim, Jordan J Feld, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 14, 2023
Controlled Human Infection Model for Hepatitis C Virus Vaccine Development: Is It Time to Be Real?
T Jake Liang, Jordan J Feld, Naglaa H Shoukry, et al.
Hepatology International
|
July 24, 2015
Optimal preservation of liver biopsy samples for downstream translational applications
Alana R Sherker, Vera Cherepanov, Zahra Alvandi, et al.
The New England Journal of Medicine
|
September 22, 2021
Controlled Human Infection Model - Fast Track to HCV Vaccine?
T Jake Liang, Jordan J Feld, Andrea L Cox, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie
|
June 22, 2012
An update on the management of hepatitis C: consensus guidelines from the Canadian Association for the Study of the Liver
Robert P Myers, Alnoor Ramji, Marc Bilodeau, et al.
The American Journal of Gastroenterology
|
September 29, 2021
Impact of COVID-19 on Prescribing Trends of Direct-Acting Antivirals for the Treatment of Hepatitis C in Ontario, Canada
Natalia Konstantelos, Ahmad Shakeri, Daniel McCormack, et al.
Canadian Journal of Gastroenterology & Hepatology
|
January 14, 2015
An update on the management of chronic hepatitis C: 2015 Consensus guidelines from the Canadian Association for the Study of the Liver
Robert P Myers, Hemant Shah, Kelly W Burak, et al.
Case Reports in Hepatology
|
November 7, 2014
Death from Liver Failure despite Lamivudine Prophylaxis during R-CHOP Chemotherapy due to Rapid Emergence M204 Mutations
Lay Lay Win, Jeff Powis, Hemant Shah, et al.
Canadian Liver Journal
|
September 22, 2022
The mean attributable health care costs associated with hepatitis B virus in Ontario, Canada: A matched cohort study
Natasha Nanwa, Jeffrey C Kwong, Jordan J Feld, et al.
Page
of 40
Search research articles
Search
Showing results (91-100 of 394) with videos related to
Sort By:
Page
of 40
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 14, 2023
First Do No Harm? Modeling Risks and Benefits of Challenge Trials for Hepatitis C Vaccine Development
Alyssa Bilinski, Rachel Slimovitch, Andrew Mendlowitz, et al.
Canadian Liver Journal
|
August 22, 2022
Cost-effectiveness of obeticholic acid for the treatment of non-alcoholic steatohepatitis: An early economic evaluation
Chanh-Phong Tran, John J Kim, Jordan J Feld, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 14, 2023
Controlled Human Infection Model for Hepatitis C Virus Vaccine Development: Is It Time to Be Real?
T Jake Liang, Jordan J Feld, Naglaa H Shoukry, et al.
Hepatology International
|
July 24, 2015
Optimal preservation of liver biopsy samples for downstream translational applications
Alana R Sherker, Vera Cherepanov, Zahra Alvandi, et al.
The New England Journal of Medicine
|
September 22, 2021
Controlled Human Infection Model - Fast Track to HCV Vaccine?
T Jake Liang, Jordan J Feld, Andrea L Cox, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie
|
June 22, 2012
An update on the management of hepatitis C: consensus guidelines from the Canadian Association for the Study of the Liver
Robert P Myers, Alnoor Ramji, Marc Bilodeau, et al.
The American Journal of Gastroenterology
|
September 29, 2021
Impact of COVID-19 on Prescribing Trends of Direct-Acting Antivirals for the Treatment of Hepatitis C in Ontario, Canada
Natalia Konstantelos, Ahmad Shakeri, Daniel McCormack, et al.
Canadian Journal of Gastroenterology & Hepatology
|
January 14, 2015
An update on the management of chronic hepatitis C: 2015 Consensus guidelines from the Canadian Association for the Study of the Liver
Robert P Myers, Hemant Shah, Kelly W Burak, et al.
Case Reports in Hepatology
|
November 7, 2014
Death from Liver Failure despite Lamivudine Prophylaxis during R-CHOP Chemotherapy due to Rapid Emergence M204 Mutations
Lay Lay Win, Jeff Powis, Hemant Shah, et al.
Canadian Liver Journal
|
September 22, 2022
The mean attributable health care costs associated with hepatitis B virus in Ontario, Canada: A matched cohort study
Natasha Nanwa, Jeffrey C Kwong, Jordan J Feld, et al.
Page
of 40